[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [All Electric Commitment From GM, Volkswagen, Could Put Lithium In A Supercycle](=) [And Look At Under-The-Radar Lithium Companies...Like This One](=) --------------------------------------------------------------- September 2, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [These 2 Dividend Stocks Pay Every Week](=) =Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.](=) = --------------------------------------------------------------- [Pinduoduo, PDD]( Recent Analyst Action: Jiong Shao, analyst at Barclays, reiterates coverage on [Pinduoduo (PDD)]()in the Consumer Goods sector with a Hold rating and a price target of $66.00 (12 hours ago). - Recent Price: $72.05 - Average Analyst Price Target: $85.41 (18.54%) - Market Cap: $89.51B [TipRanks.com](=) also reports that [Pinduoduo](currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $85.41. The target pricing ranges from a high forecast of $107.00 down to a low forecast of $66.00. [Pinduoduo (PDD)]()’s last closing price was $72.05 which would put the average price target at $85.41. Here are 3rd party ratings for [PDD](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Bottom 46% (137 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Ukraine isn't the real problem - Taiwan is.]( I thought you'd be interested in this report from Behind the Markets. [Ukraine isn't the real problem - Taiwan is.](=) Learn More [Here.](=) = --------------------------------------------------------------- [Centessa Pharmaceuticals, CNTA]() Recent Analyst Action: Matthew Harrison, analyst at Morgan Stanley, reiterates coverage on [Centessa Pharmaceuticals (CNTA)]()in the Healthcare sector with a Sell rating and a price target of $5.00 (3 weeks ago). - Recent Price: $4.75 - Average Analyst Price Target: $6.00 (26.32%) - Market Cap: $427.99M [TipRanks.com]() also reports that [Centessa Pharmaceuticals](currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $6.00. The target pricing ranges from a high forecast of $11.00 down to a low forecast of $4.00. [Centessa Pharmaceuticals (CNTA)](’s last closing price was $4.75 which would put the average price target at $6.00. Here are 3rd party ratings for [CNTA](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 32% (81 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- [CareCloud, Inc., MTBC](=) Recent Analyst Action: Marc Wiesenberger, analyst at B.Riley Financial, reiterates coverage on [CareCloud, Inc. (MTBC)](=)in the Technology sector with a Buy rating and a price target of $8.00 (4 weeks ago). - Recent Price: $3.68 - Average Analyst Price Target: $8.67 (135.60%) - Market Cap: $52.18M [TipRanks.com]() also reports that [CareCloud, Inc.](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.67. The target pricing ranges from a high forecast of $13.00 down to a low forecast of $5.00. [CareCloud, Inc. (MTBC)]()’s last closing price was $3.68 which would put the average price target at $8.67. Here are 3rd party ratings for [MTBC](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 35% (88 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Fed Exposed! Former government insider tells ALL Secret plan to destroy the markets?]( [former government insider]( just went on LIVE camera and exposed the Federal Reserve for what it REALLY is… An institution created in secret designed to rob you of your savings, and destroy your wealth. And even though we all know these central bankers have blood on their hands (inflation, the Greenspan bubble, Ben Bernanke)… No one, and I mean NO ONE expected [this](. If what this insider says is correct, you may only have days to prepare. [Click here to see his shocking exposé.](=) --------------------------------------------------------------- [Deciphera Pharmaceuticals, DCPH](=) Recent Analyst Action: Tyler Van, analyst at Cowen & Co., reiterates coverage on [Deciphera Pharmaceuticals (DCPH)](=)in the Healthcare sector with a Buy rating and a price target of $25.00 (4 days ago). - Recent Price: $17.3 - Average Analyst Price Target: $15.78 (-8.79%) - Market Cap: $1.14B [TipRanks.com]() also reports that [Deciphera Pharmaceuticals]()currently has 9 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $15.78. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $8.00. [Deciphera Pharmaceuticals (DCPH)](=)’s last closing price was $17.3 which would put the average price target at $15.78. Here are 3rd party ratings for [DCPH](=): - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (59 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Apellis Pharmaceuticals, APLS]() Recent Analyst Action: Douglas Tsao, analyst at H.C. Wainwright, reiterates coverage on [Apellis Pharmaceuticals (APLS)](in the Healthcare sector with a Buy rating and a price target of $75.00 (1 week ago). - Recent Price: $64.41 - Average Analyst Price Target: $77.43 (20.21%) - Market Cap: $6.99B [TipRanks.com]( also reports that [Apellis Pharmaceuticals](currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $77.43. The target pricing ranges from a high forecast of $113.00 down to a low forecast of $40.00. [Apellis Pharmaceuticals (APLS)](’s last closing price was $64.41 which would put the average price target at $77.43. Here are 3rd party ratings for [APLS](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (59 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Biden calls it QUITS in 30 days?](=) =A #1 ranked economist is making a bold prediction: “I predict once we start to see (this crisis) hit here in America, it will force Biden’s resignation…” [Go here now to find out the real reason why Biden could resign in the next 30 days…](=) [click](=) --------------------------------------------------------------- [RVL Pharmaceuticals, RVLP]( Recent Analyst Action: Douglas Tsao, analyst at H.C. Wainwright, reiterates coverage on [RVL Pharmaceuticals (RVLP)](=)in the Healthcare sector with a Buy rating and a price target of $5.00 (2 days ago). - Recent Price: $2.4 - Average Analyst Price Target: $5.00 (108.33%) - Market Cap: $230.03M [TipRanks.com]() also reports that [RVL Pharmaceuticals](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [RVL Pharmaceuticals (RVLP)](=)’s last closing price was $2.4 which would put the average price target at $5.00. Here are 3rd party ratings for [RVLP](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 32% (81 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- [DXC Technology, DXC](=) Recent Analyst Action: Bryan Bergin, analyst at Cowen & Co., reiterates coverage on [DXC Technology (DXC)](=)in the Technology sector with a Buy rating and a price target of $37.00 (2 weeks ago). - Recent Price: $27.495 - Average Analyst Price Target: n/a (34.13%) - Market Cap: $6.14B [TipRanks.com]() also reports that [DXC Technology]()currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $36.88. The target pricing ranges from a high forecast of $48.00 down to a low forecast of $30.00. [DXC Technology (DXC)](=)’s last closing price was $27.495 which would put the average price target at $36.88. Here are 3rd party ratings for [DXC](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 43% (144 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]() = [Click here](=) for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. To Your Financial Future, The Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States 184580309540